Contact
Please use this form to send email to PR contact of this press release:
BioCellgraft, Inc. begins strategic and comprehensive initiatives working toward OraFyl sales in dentistry for Q1,2025
TO:
Michael Wilhelm
BioCellgraft, Inc.
+1 646-502-5501